These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 8154416

  • 1. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization.
    Knuuti MJ, Saraste M, Nuutila P, Härkönen R, Wegelius U, Haapanen A, Bergman J, Haaparanta M, Savunen T, Voipio-Pulkki LM.
    Am Heart J; 1994 Apr; 127(4 Pt 1):785-96. PubMed ID: 8154416
    [Abstract] [Full Text] [Related]

  • 2. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.
    Baer FM, Voth E, Schneider CA, Theissen P, Schicha H, Sechtem U.
    Circulation; 1995 Feb 15; 91(4):1006-15. PubMed ID: 7850935
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prediction of improvement of regional left ventricular function after revascularization using different perfusion-metabolism criteria.
    Bax JJ, Visser FC, Elhendy A, Poldermans D, Cornel JH, van Lingen A, Boersma E, Sloof GW, Fioretti PM, Visser CA.
    J Nucl Med; 1999 Nov 15; 40(11):1866-73. PubMed ID: 10565782
    [Abstract] [Full Text] [Related]

  • 5. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization.
    Baer FM, Voth E, Deutsch HJ, Schneider CA, Horst M, de Vivie ER, Schicha H, Erdmann E, Sechtem U.
    J Am Coll Cardiol; 1996 Jul 15; 28(1):60-9. PubMed ID: 8752795
    [Abstract] [Full Text] [Related]

  • 6. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat.
    Ont Health Technol Assess Ser; 2005 Jul 15; 5(16):1-167. PubMed ID: 23074467
    [Abstract] [Full Text] [Related]

  • 7. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease.
    Lucignani G, Paolini G, Landoni C, Zuccari M, Paganelli G, Galli L, Di Credico G, Vanoli G, Rossetti C, Mariani MA.
    Eur J Nucl Med; 1992 Jul 15; 19(10):874-81. PubMed ID: 1451704
    [Abstract] [Full Text] [Related]

  • 8. F18-fluorodeoxyglucose single-photon emission computed tomography predicts functional outcome of dyssynergic myocardium after surgical revascularization.
    Bax JJ, Cornel JH, Visser FC, Fioretti PM, Huitink JM, van Lingen A, Sloof GW, Visser CA.
    J Nucl Cardiol; 1997 Jul 15; 4(4):302-8. PubMed ID: 9278877
    [Abstract] [Full Text] [Related]

  • 9. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium.
    Bax JJ, Visser FC, Blanksma PK, Veening MA, Tan ES, Willemsen TM, van Lingen A, Teule GJ, Vaalburg W, Lie KI, Visser CA.
    J Nucl Med; 1996 Oct 15; 37(10):1631-6. PubMed ID: 8862297
    [Abstract] [Full Text] [Related]

  • 10. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.
    vom Dahl J, Altehoefer C, Sheehan FH, Buechin P, Schulz G, Schwarz ER, Koch KC, Uebis R, Messmer BJ, Buell U, Hanrath P.
    J Nucl Med; 1997 May 15; 38(5):742-8. PubMed ID: 9170439
    [Abstract] [Full Text] [Related]

  • 11. Feasibility of assessing regional myocardial uptake of 18F-fluorodeoxyglucose using single photon emission computed tomography.
    Bax JJ, Visser FC, van Lingen A, Huitink JM, Kamp O, van Leeuwen GR, Visser GW, Teule GJ, Visser CA.
    Eur Heart J; 1993 Dec 15; 14(12):1675-82. PubMed ID: 8131767
    [Abstract] [Full Text] [Related]

  • 12. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation.
    Gerber BL, Vanoverschelde JL, Bol A, Michel C, Labar D, Wijns W, Melin JA.
    Circulation; 1996 Aug 15; 94(4):651-9. PubMed ID: 8772684
    [Abstract] [Full Text] [Related]

  • 13. F-18-FDG uptake is a reliable predictory of functional recovery of akinetic but viable infarct regions as defined by magnetic resonance imaging before and after revascularization.
    Schmidt M, Voth E, Schneider CA, Theissen P, Wagner R, Baer FM, Schicha H.
    Magn Reson Imaging; 2004 Feb 15; 22(2):229-36. PubMed ID: 15010115
    [Abstract] [Full Text] [Related]

  • 14. Metabolic responses of hibernating and infarcted myocardium to revascularization. A follow-up study of regional perfusion, function, and metabolism.
    Marwick TH, MacIntyre WJ, Lafont A, Nemec JJ, Salcedo EE.
    Circulation; 1992 Apr 15; 85(4):1347-53. PubMed ID: 1555279
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the clinical value of combination of 99mTc-MIBI myocardial SPECT and 18F-FDG PET in assessing myocardial viability.
    Zhang X, Liu X, Shi R, Wu Q, Gao R, Liu Y, Hu S, Guo S, Xie F, Li Y.
    Radiat Med; 1999 Apr 15; 17(3):205-10. PubMed ID: 10440109
    [Abstract] [Full Text] [Related]

  • 16. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease].
    vom Dahl J, Altehoefer C, Büchin P, Sheehan FH, Schwarz ER, Koch KC, Schulz G, Uebis R, Schöndube F, Messmer BJ, Büll U, Hanrath P.
    Z Kardiol; 1996 Nov 15; 85(11):868-81. PubMed ID: 9064949
    [Abstract] [Full Text] [Related]

  • 17. The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET.
    Knuuti MJ, Nuutila P, Ruotsalainen U, Teräs M, Saraste M, Härkönen R, Ahonen A, Wegelius U, Haapanen A, Bergman J.
    J Nucl Med; 1993 Dec 15; 34(12):2068-75. PubMed ID: 8254389
    [Abstract] [Full Text] [Related]

  • 18. Time dependence of residual tissue viability after myocardial infarction assessed by [18F]fluorodeoxyglucose and positron emission tomography.
    Fragasso G, Chierchia SL, Lucignani G, Landoni C, Conversano A, Gilardi MC, Colombo F, Rossetti C, Fazio F.
    Am J Cardiol; 1993 Dec 16; 72(19):131G-139G. PubMed ID: 8279350
    [Abstract] [Full Text] [Related]

  • 19. Prediction of reversible ischemia after revascularization. Perfusion and metabolic studies with positron emission tomography.
    Tamaki N, Kawamoto M, Tadamura E, Magata Y, Yonekura Y, Nohara R, Sasayama S, Nishimura K, Ban T, Konishi J.
    Circulation; 1995 Mar 15; 91(6):1697-705. PubMed ID: 7882476
    [Abstract] [Full Text] [Related]

  • 20. Low-dose dobutamine electrocardiograph-gated myocardial SPECT for identifying viable myocardium: comparison with dobutamine stress echocardiography and PET.
    Yoshinaga K, Morita K, Yamada S, Komuro K, Katoh C, Ito Y, Kuge Y, Kohya T, Kitabatake A, Tamaki N.
    J Nucl Med; 2001 Jun 15; 42(6):838-44. PubMed ID: 11390545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.